Navigation Links
ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
Date:12/4/2008

IRVINE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), an ophthalmic pharmaceutical company, today announced results from the Company's recently completed Phase III clinical program of Xibrom(TM) (0.09% bromfenac sodium ophthalmic solution) QD (once-daily). The program enrolled 282 patients who underwent cataract surgery in two U.S. multi-center, randomized, double-masked, parallel-group, vehicle-controlled studies to evaluate Xibrom 0.09% dosed once daily to vehicle (placebo). The identical trials were performed under a common protocol and designated the East region trial (ER) and the West region trial (WR).

According to a preliminary analysis, integrated results for the two studies demonstrated Xibrom 0.09% QD achieved statistical significance in meeting the primary efficacy endpoint of absence of ocular inflammation 15 days following surgery. In addition, Xibrom 0.09% QD met the secondary efficacy endpoint of elimination of ocular pain one day post surgery.

When considered independently, the WR trial showed statistical significance in both the primary and secondary efficacy endpoints. The ER exhibited strong trends in both the absence of ocular inflammation and pain but did not meet statistical significance for either. The rate of patients who discontinued due to lack of efficacy in the ER was six times greater than the WR trial and a previous clinical trial utilizing the same protocol and concentration. In addition, there was a 20 percentage-point higher placebo effect for the relief of pain in the ER compared with the WR results and with previous trial experience with bromfenac ophthalmic solution. Despite the unexpected results reported for the ER Phase III study, there were strong trends in favor of statistical efficacy.

In addition, both Phase III studi
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
4. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
5. Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia
6. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
9. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
10. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
11. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Dec. 1 WebMD Health Co... information, today announced the honorees of the ... WebMD Health Heroes honor Americans with extraord..., who lead an effort to help others achieve better...m/cgi-bin/prnh/20091201/NY18114 ) ,, "WebMD is...
(Date:12/1/2009)...Dec. 1 CryoLife, Inc. (...nd cardiovascular tissue processing company, annou..., The Company expects total revenues for the full ....0 million, which includes between $1.5 million an...e Department of Defense in connection with the dev...
(Date:12/1/2009)...E, Md., Dec. 1 Sleep Solutions...vider for home testing and evaluation of sleep-dis...chard Hassett, M.D., as its chief executive office...Healthcare, during its growth from a $250 million ...ustry leader in total population health, and its s...
Breaking Medicine Technology:WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Environmentally green beer 3A Munich brewing engineers research energy savings 9825 1Environmentally green beer 3A Munich brewing engineers research energy savings 9825 2Environmentally green beer 3A Munich brewing engineers research energy savings 9825 3Composted dairy manure in foliage plant production 9823 1Composted dairy manure in foliage plant production 9823 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2
... Plan Positions Blue Cross Blue Shield of Mic...rt from HealthLeaders-Inter...terStudy, the,leading provider of managed care mar...inues to stagnate in Michigan, Blue Cross Blue Shi...f its competitors to weather the,economic storm be...
...n,Pharmaceuticals Limited (ASX:PGL; Nasdaq: PGLA) ...nt enrolment in the phase 1 dose-escalation study,...047 (formerly CGC-11047),for patients with advance...-11047 - the lead clinical,compound in the Company...f,Cellgate, Inc earlier this year. The first patie...
Other Medicine Technology:Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2
(Date:12/1/2009)... -- Reportlinker.com announces that a new market r..., Emerging Clinical Trial Locations - India: Mar...atory environment ,, http://www.reportlinker...India-Market-dynamics-and-the-changing-healthcare-...st decade pharmaceutical and biotechnology compani...
(Date:12/1/2009)...ire/ -- As health care reform takes the national s...re delivery model, renowned entrepreneur Henry J. ...Hall of Fame. Kaiser,s eldest granddaughter, Carly...ia medal on his behalf during a formal, private st...iser,s greatest legacy is Kaiser Permanente, one o...
(Date:12/1/2009)...e easily identified, study finds , , TUE...ance imaging test is highly effective at detecting...placenta accreta, researchers report. , The con...s attaches too deeply to a woman,s uterus. During ...terine wall, rupturing blood vessels and putting t...
(Date:12/1/2009)...e-USNewswire/ -- The American Society of Hematolog...ymposium at the New Orleans Marriott on Thursday, ... encourages an interest in hematology, the biologi...junction with the Society,s 51st Annual Meeting. T...plore research on sickle cell disease, an inherite...
(Date:12/1/2009)...re/ -- A national survey reveals the majority of m...s and themselves but at the same time want the rig...milies. ,, See video from HealthyWomen at: htt...of mothers of children aged 12 months and younger ...eding decision prior to going to the hospital to g...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 2Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 3Health News:Serious Pregnancy Complication Detected With MRI 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2
...rs say health professionals and patients require e... the risks associated with over the counter drugs....e of the most common condition that people choose ...n, coughs, colds, and acid stomach. The report ...
...y occurring radioactive gas// without odour, colou...t emanates from the ground into the air. Radon gas...n depending on the highly variable uranium content...lectrically charged and attach to aerosols, dust a...
...ording to the research finding published by the Am...een found that calorie intake may not be a major f...inding was based on a 17-year study of almost 9,79...rticipants were grouped based on reports of calori...
...levels of children exposed to the epilepsy drug in...ere not exposed to the drug.// The study was co...16 who were born to mothers with epilepsy and test...oic acid during pregnancy had an average verbal IQ...
...he next food enlisted in breast cancer prevention,...dy conducted at the University of California. In t...aweed effectively reduced levels of estradiol, // ... good sign when it comes to preventing breast canc...
...ncer – melanoma ,however researchers as the number...s the number of patients surviving the disease. //...ficial influence on some kinds of cancer. In a stu... of sun exposure were less likely to die. Non-H...
Other Medicine News:Health News:WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon 2
QualCraft™ Gamekeeper Thumb Stabilizer
...tion can be difficult for persons who have suffere...and for children with poor hand control due to cer...s. The FoamWrap ThumDuction Strap positions the th...material provides light control and positioning to...
...amWrap ThumWrap Splints offer support without the ...lieve mild pain or strain due to repetitive stress... rigid or the flexible stay to provide just the ri...e ThumWrap Splint is comfortable to wear even in t...
...s an off-the-shelf wrist orthotic designed to limi...ges-of-motion (20°,35° and 50°). , ,I...ins with TFCC tear-triangular fibrocartilage compl... nonunion , Partial tendon rupture , ORIF - Op...
Medicine Products: